乳腺癌/卵巢癌家族中BRCA1/2突变的高敏感性：是否仍有其他乳腺癌/卵巢癌相关基因有待发现？ - Suppr | 超能文献

High sensitivity for BRCA1/2 mutations in breast/ovarian kindreds: are there still other breast/ovary genes to be discovered?

作者信息

Smith Miriam J, Gifford Franchesca L, Lalloo Fiona, Newman William G, Evans D Gareth R

出版信息

Breast Cancer Res Treat. 2012 Jul;134(2):895-7. doi: 10.1007/s10549-012-2130-5. Epub 2012 Jul 3.

DOI:10.1007/s10549-012-2130-5

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

High sensitivity for BRCA1/2 mutations in breast/ovarian kindreds: are there still other breast/ovary genes to be discovered?乳腺癌/卵巢癌家族中BRCA1/2突变的高敏感性：是否仍有其他乳腺癌/卵巢癌相关基因有待发现？

Breast Cancer Res Treat. 2012 Jul;134(2):895-7. doi: 10.1007/s10549-012-2130-5. Epub 2012 Jul 3.

2

Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing.BRCA1/2 基因突变在散发性乳腺癌/卵巢癌患者中的流行情况，以及在诊断为晚发性乳腺癌和卵巢癌的患者中发现一种新的从头 BRCA1 突变：对遗传检测的影响。

Breast Cancer Res Treat. 2012 Feb;132(1):87-95. doi: 10.1007/s10549-011-1544-9. Epub 2011 May 7.

3

Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members.BRCA1 和 BRCA2 剪接变异体的特征：ENIGMA 联盟成员的协作报告。

Breast Cancer Res Treat. 2012 Apr;132(3):1009-23. doi: 10.1007/s10549-011-1674-0. Epub 2011 Jul 19.

4

Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age.BRCA1 和 BRCA2 家族乳腺癌、卵巢癌和对侧乳腺癌的外显率：老年时癌症发病率高。

Breast Cancer Res Treat. 2010 Dec;124(3):643-51. doi: 10.1007/s10549-010-0805-3. Epub 2010 Mar 4.

5

Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer.泰国家族性和散发性早发性乳腺癌及卵巢癌中乳腺癌易感基因BRCA1和BRCA2的分析

Hum Mutat. 2002 Sep;20(3):230. doi: 10.1002/humu.9049.

6

Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia.斯洛伐克遗传性乳腺癌/卵巢癌家系的综合遗传特征分析。

Breast Cancer Res Treat. 2011 Feb;126(1):119-30. doi: 10.1007/s10549-010-1325-x. Epub 2011 Jan 4.

7

Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.意大利乳腺癌和/或卵巢癌家族中新型BRCA1和BRCA2种系突变以及突变谱和患病率评估

Breast Cancer Res Treat. 2006 Nov;100(1):83-91. doi: 10.1007/s10549-006-9225-9. Epub 2006 May 9.

8

Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.对来自乳腺癌-卵巢癌家族的BRCA1和BRCA2阴性先证者、早发性乳腺癌病例及对照个体中与BRCA1相互作用的基因ZNF350/ZBRK1和BRIP1/BACH1进行突变分析。

Hum Mutat. 2003 Aug;22(2):121-8. doi: 10.1002/humu.10238.

9

Evaluation of RAD51C as cancer susceptibility gene in a large breast-ovarian cancer patient population referred for genetic testing.评估 RAD51C 作为大型乳腺癌-卵巢癌患者遗传检测人群中的癌症易感性基因。

Breast Cancer Res Treat. 2012 May;133(1):393-8. doi: 10.1007/s10549-012-1998-4. Epub 2012 Feb 28.

10

Hereditary breast and ovarian cancer in Andalusian families: a genetic population study.安达卢西亚家族遗传性乳腺癌和卵巢癌：一项遗传人群研究。

BMC Cancer. 2018 Jun 8;18(1):647. doi: 10.1186/s12885-018-4537-9.

引用本文的文献

1

Risk algorithms that include pathology adjustment for HER2 amplification need to make further downward adjustments in likelihood scores.包含对HER2扩增进行病理调整的风险算法需要在可能性评分上进一步向下调整。

Fam Cancer. 2017 Apr;16(2):173-179. doi: 10.1007/s10689-016-9942-0.

2

Sensitivity of BRCA1/2 testing in high-risk breast/ovarian/male breast cancer families: little contribution of comprehensive RNA/NGS panel testing.BRCA1/2检测在高危乳腺癌/卵巢癌/男性乳腺癌家族中的敏感性：综合RNA/NGS panel检测贡献不大。

Eur J Hum Genet. 2016 Nov;24(11):1591-1597. doi: 10.1038/ejhg.2016.57. Epub 2016 Jun 8.